Literature DB >> 10457320

Effect of microscopic resection line disease on gastric cancer survival.

S H Kim1, M S Karpeh, D S Klimstra, D Leung, M F Brennan.   

Abstract

To study the effect of residual microscopic resection line disease in gastric cancer, we compared 47 patients with positive margins to 572 patients who underwent R0 resections using a multivariate analysis of factors affecting outcome. Although the presence of positive margins was a significant and independent predictor of outcome for the entire group (N = 619), this factor lost significance in patients who had undergone D2 or D3 lymph node dissections (N = 466). Subset analysis within the D2/D3 group determined that this finding was limited mainly to those patients with.5 positive nodes (N = 189). The survival of patients who had </=5 positive nodes (N = 277) was significantly worsened by a microscopically involved margin. Supporting this observation, intraoperative reexcision of microscopic disease based on frozen section analysis resulted in a significant improvement in overall survival in patients with </=5 positive nodes but not in those with >5 positive nodes. We conclude that the significance of a positive microscopic margin in gastric cancer is dependent on the extent of disease. This factor is not predictive of outcome in patients who have undergone complete gross resection and have pathologically proved advanced nodal disease. Thus the goal in these cases should be an R0 resection when feasible but with the realization that the presence of >/=5 positive nodes (N2 disease according to the 1997 American Joint Committee on Cancer criteria) will mainly determine outcome and not microscopic residual cancer at the margin.

Entities:  

Mesh:

Year:  1999        PMID: 10457320     DOI: 10.1016/s1091-255x(99)80004-3

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.267


  13 in total

1.  Adenocarcinoma of the stomach: current results of treatment.

Authors:  L S Bizer
Journal:  Cancer       Date:  1983-02-15       Impact factor: 6.860

2.  Proximal gastric cancers resected via a transabdominal-only approach. Results and comparisons to distal adenocarcinoma of the stomach.

Authors:  L E Harrison; M S Karpeh; M F Brennan
Journal:  Ann Surg       Date:  1997-06       Impact factor: 12.969

3.  Adenocarcinoma of the gastric cardia. Recurrence and survival after resection.

Authors:  J G Blomjous; W C Hop; B L Langenhorst; F J ten Kate; W M Eykenboom; H W Tilanus
Journal:  Cancer       Date:  1992-08-01       Impact factor: 6.860

4.  Positive proximal resection margins after resection for carcinoma of the oesophagus and stomach: effect on survival and symptom recurrence.

Authors:  C A Gall; N A Rieger; D A Wattchow
Journal:  Aust N Z J Surg       Date:  1996-11

5.  Prognostic factors in adenocarcinoma of the cardia.

Authors:  R J Jakl; J Miholic; R Koller; E Markis; E Wolner
Journal:  Am J Surg       Date:  1995-03       Impact factor: 2.565

6.  Prognostic value of resection-line involvement in patients undergoing curative resections for gastric cancer.

Authors:  I Songun; J J Bonenkamp; J Hermans; J H van Krieken; C J van de Velde
Journal:  Eur J Cancer       Date:  1996-03       Impact factor: 9.162

7.  Resection margin in patients with gastric cancer associated with esophageal invasion: clinicopathological study.

Authors:  T Yokota; K Sawai; T Yamaguchi; H Taniguchi; S Shimada; C Yoneyama; T Takahashi
Journal:  J Surg Oncol       Date:  1993-05       Impact factor: 3.454

8.  Local recurrence of gastric adenocarcinomas after gastrectomy.

Authors:  D N Papachristou; J G Fortner
Journal:  J Surg Oncol       Date:  1981       Impact factor: 3.454

9.  Adenocarcinoma of the stomach: a multivariate analysis of clinical, pathologic and treatment factors.

Authors:  M H Shiu; M Perrotti; M F Brennan
Journal:  Hepatogastroenterology       Date:  1989-02

10.  Histologically positive esophageal margin in the surgical treatment of gastric cancer.

Authors:  D N Papachristou; N Agnanti; H D'Agostino; J G Fortner
Journal:  Am J Surg       Date:  1980-05       Impact factor: 2.565

View more
  39 in total

1.  A decade in gastric cancer curative surgery: Evidence of progress (1999-2009).

Authors:  Stefano Rausei; Gianlorenzo Dionigi; Francesca Rovera; Luigi Boni; Caterina Valerii; Luisa Giavarini; Francesco Frattini; Renzo Dionigi
Journal:  World J Gastrointest Surg       Date:  2012-03-27

2.  Outcomes of Abdominal Total Gastrectomy for Type II and III Gastroesophageal Junction Tumors: Single Center's Experience in Korea.

Authors:  Kyoung Tai Kim; Oh Jeong; Mi Ran Jung; Seong Yeop Ryu; Young-Kyu Park
Journal:  J Gastric Cancer       Date:  2012-03-30       Impact factor: 3.720

3.  Adopting postoperative chemoradiotherapy in resected gastric cancer.

Authors:  John S Macdonald
Journal:  Gastrointest Cancer Res       Date:  2009-11

4.  Treatment of resectable gastric cancer.

Authors:  Johan L Dikken; Cornelis J H van de Velde; Daniel G Coit; Manish A Shah; Marcel Verheij; Annemieke Cats
Journal:  Therap Adv Gastroenterol       Date:  2012-01       Impact factor: 4.409

5.  Prognostic impact of microscopic tumor involved resection margin in advanced gastric cancer patients after gastric resection.

Authors:  Jung-Woo Woo; Keun Won Ryu; Ji Yeon Park; Bang Wool Eom; Mi Jung Kim; Hong Man Yoon; Sook Ryun Park; Myeong-Cherl Kook; Il Ju Choi; Young-Woo Kim; Young-Iee Park
Journal:  World J Surg       Date:  2014-02       Impact factor: 3.352

6.  Metastatic lymph node ratio: a new staging system for gastric cancer.

Authors:  Roberto Persiani; Stefano Rausei; Vincenzo Antonacci; Alberto Biondi; Francesco Casella; Luigi Ciccoritti; Domenico D'Ugo
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

7.  In vivo evaluation of a modified linear stapling device designed to facilitate accurate pathologic examination of the surgical margin.

Authors:  Hironori Tsujimoto; Hitoshi Tsuda; Shuichi Hiraki; Shinsuke Nomura; Nozomi Ito; Kyohei Kanematsu; Hiroyuki Horiguchi; Suefumi Aosasa; Junji Yamamoto; Kazuo Hase
Journal:  Gastric Cancer       Date:  2015-07-22       Impact factor: 7.370

Review 8.  [R1 resection for gastric carcinoma].

Authors:  K Ridwelski; J Fahlke; M Huß; R Otto; S Wolff
Journal:  Chirurg       Date:  2017-09       Impact factor: 0.955

9.  Adjuvant chemoradiotherapy versus adjuvant chemotherapy for R1 resected gastric cancer: a retrospective cohort study.

Authors:  Meng-Long Zhou; Gui-Chao Li; Wang Yang; Wei-Juan Deng; Ran Hu; Yan Wang; Zi-Wen Long; Xiao-Wen Liu; Ya-Nong Wang; Zhen Zhang
Journal:  Br J Radiol       Date:  2018-06-27       Impact factor: 3.039

10.  Resection line involvement after gastric cancer surgery: clinical outcome in nonsurgically retreated patients.

Authors:  P Morgagni; D Garcea; D Marrelli; G De Manzoni; G Natalini; H Kurihara; A Marchet; L Saragoni; E Scarpi; C Pedrazzani; A Di Leo; F De Santis; V Panizzo; D Nitti; F Roviello
Journal:  World J Surg       Date:  2008-12       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.